Is cycloserine an imported drug? Where does it come from?

Cycloserine (Cycloserine) was first discovered and put into use in the 1950s. It was initially developed and produced by American pharmaceutical companies, so historically it was a typical imported drug. With the development of global tuberculosis prevention and control work, this drug has gradually been used in many countries. Cycloserine is a second-line anti-tuberculosis drug and plays an important role in the treatment of multidrug-resistant tuberculosis (MDR-TB). In the early days, cycloserine used in the Chinese market mainly relied on imported sources, and common supplying countries included the United States, India and other places. However, in recent years, with the development of domestic pharmaceutical technology, cycloserine has been produced domestically, has been approved and marketed in China, and is widely used in clinical treatments.

Currently, cycloserine has not only been launched in China, but has also been included in the Category B scope of the National Medical Insurance Directory. The common specification is250mg*10 tablets, which provides a more convenient and economical choice for tuberculosis patients. The policy of medical insurance reimbursement further reduces the financial burden on patients, allowing more people to afford standardized treatment. It needs to be emphasized that although cycloserine was an imported drug in the early days, the quality control system of domestic pharmaceutical companies has been continuously improved, and domestic cycloserine can meet clinical needs in terms of efficacy and safety.

For patients, whether it is imported or domestically produced, the key is that the drug is from a regular source, has reliable quality, and is used strictly in accordance with the doctor's prescription. It is worth mentioning that with the globalization of tuberculosis treatment, different countries maintain cooperation in the drug supply chain, which also provides guarantee for the continuity of patient medication. To sum up, cycloserine originally originated from abroad, but now it has been widely marketed in China and entered into medical insurance. The difference between domestically produced and imported drugs has gradually narrowed, and patients can safely obtain the drugs they need for treatment through formal channels.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine